Portable Osteoporosis Screening Device
About 75% of osteoporotic patients are undiagnosed due to the fact that osteoporosis diagnostics are performed only at the secondary care level. Bindex® was created to cover this early diagnosis gap. Bindex® as been validated according to international guidelines, and its measurements are thus comparable to standard diagnostic procedures (axial DXA, X-ray device).
Bindex ® offers accurate results, which are comparable to dual energy X-ray absorptiometry (DXA). During clinical trials, it has a 90% accuracy rate in detecting osteoporosis or detecting an increased risk for the disease. Bindex ® can replace nearly 70% of DXA scans.